Research - malecare.org

Yale Researchers Present Results of Phase II Phenoxodiol Clinical Trial in Prostate Cancer Patients at ASCO 2009 Genitourinary Cancers Symposium

Marshall Edwards, Inc. (NASDAQ: MSHL) is planning to release preliminary results from a Phase II clinical trial of oral phenoxodiol in patients with early and advanced stage prostate cancer. The results will be presented by the Yale researchers, who were responsible for the study, at the ASCO Genitourinary Cancers Symposium in Orlando, Florida; February 26-28, [...]

By Malecare|2017-10-19T10:56:04-04:00February 25th, 2009|Advanced Prostate Cancer, Clinical Trials, Clinical Trials, Research, Uncategorized|0 Comments

A Possible Surrogate Endpoint- Circulating Tumor Cells

There is nothing more frustration that the current methods used by the FDA to approve drugs. The theory is great, but how it gets translated into our real world is killer, I mean a literal killer of men. The FDA wants assurances that before they approve a drug that it really works, or shows efficacy. [...]

By Malecare|2020-02-04T10:39:49-05:00February 12th, 2009|Advanced Prostate Cancer, Clinical Trials, Clinical Trials, Research, Uncategorized, Understanding APC|0 Comments

Algeta, Completing A Successful Phase II Trial For Men With Bone Metastases Will Begin Enrolling US Survivors Into A Phase III Trial

Algeta ASA (OSE: ALGETA), has announced that it will begin to enroll US survivors into its Alsympca phase III trial evaluating Alpharadin (radium-223). Alpharadin is designed to be used as a treatment for bone metastases in prostate cancer survivors with hormone-refractory prostate cancer (HRPC). The announcement of the trial follows a successful end-of-phase II meeting [...]

By Malecare|2021-02-17T10:45:20-05:00February 4th, 2009|Advanced Prostate Cancer, Alpharadin (radium-223), Clinical Trials, Clinical Trials, Metastases, Research, Uncategorized, Understanding APC|0 Comments

The Role of BRCA1 and BRCA2 Gene Mutations in Advanced Prostate Cancer

Sure, we need more research about prostate cancer, but fortunately we also gain from research into other cancers. The commonly referred to breast cancer genes, BRCA1 and BRCA2 might also increase a man’s risk for developing an aggressive strain of prostate cancer. According to a report in Reuters, men with prostate cancer who also carry [...]

By Malecare|2017-10-19T10:56:20-04:00February 1st, 2009|Advanced Prostate Cancer, General Information, genetics, Prostate Ponderings, Research, Uncategorized, Understanding APC|0 Comments

Gabapentin to Treat Hot Flashes

I suffered with significant hot flashes when I was on androgen deprivation therapy (ADT). I experienced between seven to 15 flashes in a twenty-four hour period. Often the flashes were accompanied with breathing difficulties and fatigue. My quality of life was significantly negatively affected. The flashes were significant enough to require that I occasionally change [...]

By Malecare|2009-01-21T12:55:41-05:00January 21st, 2009|Advanced Prostate Cancer, Clinical Trials, Clinical Trials, Hormone Therapy, Research, Uncategorized, Understanding APC|0 Comments